Videos
Watch our experts break down complex topics and suggest ways to adjust your business. Gain clarity, step-by-step.
Cell and Gene Therapy in Oncology, Part III
Tune into another episode of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, the final in our series on cell and gene therapies, experts from our Market Access practice discuss the need for patient support in cell and gene therapies, and the role that manufacturers and other stakeholders can play in providing it.
Medicare Part D, Part I: Key Trends and Pressures
Tune into the first episode of the Avalere Health Essential Voice miniseries focused on Medicare Part D. In this segment, our Policy and Market Access experts discuss Part D trends and pressures in the currently evolving drug pricing environment.
What’s Next for Health Policy on Capitol Hill?
Tune into another episode of Avalere Health Essential Voice. In this segment, Avalere policy expert Matt Kazan discusses what he expects to see from a legislative perspective this fall on Capitol Hill.
The Coverage Gap and Medicaid Expansion
Tune into another episode of Avalere Health Essential Voice. In this segment, our experts discuss the forthcoming debate around the coverage gap in non-Medicaid expansion states, potential policy options, and the impact on key stakeholders.
Cell and Gene Therapy in Oncology, Part II
Tune into another episode of the Avalere Health Essential Voice podcast series focused on disease education. In this segment, the second in a series focused on cell and gene therapies, experts from our Policy and Market Access practices discuss value-based payment arrangements in cell and gene therapies, and the role they play in facilitating access to these therapies.
Huntington’s Disease: Challenges and Treatment
Tune into another episode in the Avalere Health Essential Voice podcast series focused on disease education. In this segment, our experts from the Center for Healthcare Transformation discuss Huntington’s Disease, its impact on caregivers, the complexities of genetic testing, and potential treatment options for this rare disorder.
COVID-19 and Oncology Care
Tune into another episode in the Avalere Health Essential Voice series focused on disease education. In this segment, experts from Community Oncology Alliance (COA) and Texas Oncology join us to discuss the impact of COVID-19 on oncology care from a provider and patient perspective.
Oncology Care and NCCN Key Takeaways
Tune into another episode of the Avalere Health Essential Voice series focused on disease education. In this segment, our Market Access experts discuss major takeaways from the 2021 NCCN annual conference in the areas of diagnostics, holistic approaches to cancer treatment, and how the pandemic has influenced cancer care.
Malnutrition and Quality Improvement
Tune into another episode of Avalere Health Essential Voice. In this segment of our Disease Education series, experts from our Center for Healthcare Transformation discuss the burden of malnutrition on our healthcare system and how an Avalere-led quality improvement initiative has helped systems across the country improve malnutrition identification and treatment.
Patient Support Programs and Rare Disease
Tune into the second segment of the Avalere Health Essential Voice series focused on disease education. In this segment, experts from our Market Access practice discuss rare disease patient support programs and the need for stakeholder partnerships to address many of the barriers patients and their caregivers face.
Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma
Tune into our first episode in the Avalere Health Essential Voice series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma.
What’s Next for Telehealth?
Tune into another episode of Start Your Day with Avalere. In this segment, our experts discuss the state of the telehealth sector, the issue of payment for virtual care, and the future of telehealth.
Social Determinants of Health: The Importance of Data, Part 2
Tune into the second segment of the Avalere Health Essential Voice podcast series focused on social determinants of health (SDOH) data. In this segment, Avalere experts discuss how life sciences organizations are beginning to recognize the importance and impact of this data, particularly in real-world evidence value demonstration work.
Social Determinants of Health: The Importance of Data, Part 1
In Part 1 of this segment focused on social determinants of health (SDOH), our experts from Avalere’s Health Economics and Advanced Analytics practice discuss the importance of SDOH data, how health plans are increasingly utilizing that data, and the ongoing limitations to data access.
2020 Election with Avalere: COVID-19 Stakeholder Impacts
Tune into our seventh video of the Avalere Health Essential Voice: Election 2020 series. As election day approaches, our experts share their thoughts on how the COVID surge has changed the campaigns’ closing arguments, the current outlook on a COVID relief package, and how the election results will affect individual stakeholders.
2020 Election with Avalere: How Are Public Healthcare Programs Expanding?
Tune into our sixth video of the Avalere Health Essential Voice: 2020 Election series. In this segment, our experts discuss how we might see public healthcare programs expand under each candidate and what it might mean for future legislation.
2020 Election with Avalere: SCOTUS ACA Outlook
Tune into the fifth video of the Avalere Health Essential Voice: 2020 Election series. In this segment, our experts discuss the evolving makeup of the Supreme Court and the outlook on California vs. Texas — the upcoming Supreme Court case regarding the constitutionality of the Affordable Care Act and, in particular, the individual mandate.
2020 Election with Avalere: First Presidential Debate Healthcare Recap
Watch the fourth video in the Avalere Health Essential Voice: 2020 Election series. In this segment, our experts discuss top healthcare issues and platforms from the first Presidential debate, including the Affordable Care Act (ACA), COVID-19, public health, health disparities, and drug-pricing reform.
2020 Election with Avalere: What Are the Drug Pricing Policies?
Tune into our third episode of the Avalere Health Essential Voice: 2020 Election series. In this segment, our experts discuss candidates’ respective approaches to drug pricing policies, and where there is unexpected overlap.
2020 Election with Avalere: What are the Differences in Healthcare Platforms?
Tune into our second episode of the Avalere Health Essential Voice: 2020 Election series. In this segment, experts from the policy and vaccines teams discuss the healthcare themes heard at the recent political conventions, and differences we can expect to see in the candidates’ healthcare platforms.